psilocybin
Recent scientific advancements have shed light on the potential synergistic effects of meditation and psychedelic substances. A study published in Scientific Reports reveals how psilocybin, a psychedelic compound, when combined with open monitoring meditation may enhance the depth of insightfulness in experienced meditators. This enhancement appears to be mediated by changes in the brain’s organizational patterns. Open monitoring meditation is a type of meditation that emphasizes the broad, non-reactive awareness of the content of experience from moment to moment. Unlike focused attention medi...
PsyPost
Recent scientific advancements have shed light on the potential synergistic effects of meditation and psychedelic substances. A study published in Scientific Reports reveals how psilocybin, a psychedelic compound, when combined with open monitoring meditation may enhance the depth of insightfulness in experienced meditators. This enhancement appears to be mediated by changes in the brain’s organizational patterns. Open monitoring meditation is a type of meditation that emphasizes the broad, non-reactive awareness of the content of experience from moment to moment. Unlike focused attention medi...
PsyPost (CA)
Psilocybin, a psychedelic compound found in “magic mushrooms,” has shown promise in the treatment of mental health conditions. However, the substances is also known to induce acute anxiety. New research published in iScience00908-8) sheds light on the biological underpinnings of this anxiety, suggesting it stems from different brain processes than those driving the psychedelic effects. “While many scientific studies are currently looking into how psychedelics in general, and psilocybin in particular, may be used clinically to reduce depression and anxiety in the long term, only a handful of st...
PsyPost
Psilocybin, a psychedelic compound found in “magic mushrooms,” has shown promise in the treatment of mental health conditions. However, the substances is also known to induce acute anxiety. New research published in iScience00908-8) sheds light on the biological underpinnings of this anxiety, suggesting it stems from different brain processes than those driving the psychedelic effects. “While many scientific studies are currently looking into how psychedelics in general, and psilocybin in particular, may be used clinically to reduce depression and anxiety in the long term, only a handful of st...
PsyPost (UK)
In recent years, interest in psychedelic-assisted therapy has grown due to its potential to treat various psychological disorders such as depression, anxiety, and post-traumatic stress disorder. However, a new study published in the Journal of Psychedelic Studies raises important concerns. It suggests that while there may be benefits, there are also significant risks. The study focuses on the negative effects reported by therapists who facilitate such treatments, highlighting that the impacts of psilocybin are not universally beneficial and can vary widely from one individual to another. Psilo...
PsyPost
In recent years, interest in psychedelic-assisted therapy has grown due to its potential to treat various psychological disorders such as depression, anxiety, and post-traumatic stress disorder. However, a new study published in the Journal of Psychedelic Studies raises important concerns. It suggests that while there may be benefits, there are also significant risks. The study focuses on the negative effects reported by therapists who facilitate such treatments, highlighting that the impacts of psilocybin are not universally beneficial and can vary widely from one individual to another. Psilo...
PsyPost (CA)
In recent years, interest in psychedelic-assisted therapy has grown due to its potential to treat various psychological disorders such as depression, anxiety, and post-traumatic stress disorder. However, a new study published in the Journal of Psychedelic Studies raises important concerns. It suggests that while there may be benefits, there are also significant risks. The study focuses on the negative effects reported by therapists who facilitate such treatments, highlighting that the impacts of psilocybin are not universally beneficial and can vary widely from one individual to another. Psilo...
PsyPost (UK)
Scientists have recently discovered that psilocybin, the active ingredient in “magic mushrooms,” can significantly reduce chronic pain in rats. Notably, this pain relief was related to pain from touch, but not pain from heat. The study was published in Current Biology01374-X). Psychedelic drugs have recently gained attention for their potential to treat various psychiatric disorders. Psilocybin, in particular, has been the subject of research for its therapeutic effects on treatment-resistant depression as well as alcohol and tobacco abuse. Led by Nicholas Kolbman, researchers from the Univers...
PsyPost (CA)
Scientists have recently discovered that psilocybin, the active ingredient in “magic mushrooms,” can significantly reduce chronic pain in rats. Notably, this pain relief was related to pain from touch, but not pain from heat. The study was published in Current Biology01374-X). Psychedelic drugs have recently gained attention for their potential to treat various psychiatric disorders. Psilocybin, in particular, has been the subject of research for its therapeutic effects on treatment-resistant depression as well as alcohol and tobacco abuse. Led by Nicholas Kolbman, researchers from the Univers...
PsyPost
Scientists have recently discovered that psilocybin, the active ingredient in “magic mushrooms,” can significantly reduce chronic pain in rats. Notably, this pain relief was related to pain from touch, but not pain from heat. The study was published in Current Biology01374-X). Psychedelic drugs have recently gained attention for their potential to treat various psychiatric disorders. Psilocybin, in particular, has been the subject of research for its therapeutic effects on treatment-resistant depression as well as alcohol and tobacco abuse. Led by Nicholas Kolbman, researchers from the Univers...
PsyPost (UK)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら